ARTICLE

DNA-testing company 23andMe has signed a $300 million deal with a drug giant

- Business Insider (2019)

A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.

saved by: FoundryBase
updated 13 days ago
Visibility: Public (all visitors)


View All Articles

Comments

No comments yet. Be the first to comment!

Related Chunks

Related chunks with this resource

This Article can be found in 2 chunks
Drug Research and the Pharma industry
A collection of articles about Drug Research and the Pharma industry
FoundryBase 13 resources
Genealogy tracking, DNA and direct-to-consumer genetic-testing
Genealogy tracking, DNA and direct-to-consumer genetic-testing industry
FoundryBase 17 resources

MORE RESOURCES FROM SOURCE

More in FoundryBase from   Business Insider